HGF and COVID-19: A majority of the molecules overproduced in patients with OA also contribute to the progression of COVID-19, with only two molecular entities, HGF and CALCA factors (32, 33), noted as potential suppressors of COVID-19 phenotypes capable of preventing pulmonary fibrosis as well as local and systemic inflammation.